全科 (3209.TW) 2025Q3 financial report shows net profit of 299.44M TWD, with a YoY growth rate of 22.65%, clearly higher than last year, showing strong profit momentum and good management efficiency. It is recommended to monitor revenue, cash flow, and industry trends, and use Growin AI Value Analysis to seize growth opportunities. Overall, the company has shown a solid growth curve and future performance is worth watching.